| 000 | 01882 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513133005.0 | ||
| 264 | 0 | _c19980128 | |
| 008 | 199801s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/JVI.72.1.396-404.1998 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrkola, A | |
| 245 | 0 | 0 |
_aGenetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. _h[electronic resource] |
| 260 |
_bJournal of virology _cJan 1998 |
||
| 300 |
_a396-404 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xvirology |
| 650 | 0 | 4 | _aChemokine CCL3 |
| 650 | 0 | 4 | _aChemokine CCL4 |
| 650 | 0 | 4 |
_aChemokine CCL5 _xpharmacology |
| 650 | 0 | 4 | _aChemokine CXCL12 |
| 650 | 0 | 4 |
_aChemokines _xpharmacology |
| 650 | 0 | 4 | _aChemokines, CXC |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xmetabolism |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xvirology |
| 650 | 0 | 4 |
_aReceptors, CCR5 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, CXCR4 _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aPaxton, W A | |
| 700 | 1 | _aMonard, S P | |
| 700 | 1 | _aHoxie, J A | |
| 700 | 1 | _aSiani, M A | |
| 700 | 1 | _aThompson, D A | |
| 700 | 1 | _aWu, L | |
| 700 | 1 | _aMackay, C R | |
| 700 | 1 | _aHoruk, R | |
| 700 | 1 | _aMoore, J P | |
| 773 | 0 |
_tJournal of virology _gvol. 72 _gno. 1 _gp. 396-404 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.72.1.396-404.1998 _zAvailable from publisher's website |
| 999 |
_c9389809 _d9389809 |
||